HLB’s 1QFY17 net profit saw a 7.9% yoy (-2.8% qoq) improvement, driven by expanded operating profit (retail banking and treasury) and a higher international contribution. NIM improved while asset quality remained intact. Results were however below our expectations. Maintain HOLD, PT adjusted downward to RM13.00 from RM13.30.
Hong Leong Bank’s (HLB) 1QFY17 net profit rose by 7.9% yoy (but was down 2.8% qoq, as net credit recoveries reversed) to RM542.6m as preprovision operating profit (PPOP) saw a more robust expansion of 8.0% yoy (driven by retail banking and Treasury). Contributions from associates and the JV gave another boost to the bottom line (+11.7% yoy, +12% qoq). The 1QFY17 results, which represented 22% of our FY17 forecast, were below our expectations (but within consensus) due to lower-than-expected fund-based income, though our forecasts on impaired loan allowances are more conservative. Highlights of the 1QFY17 results include: i) NIM improvement of 7bps yoy and 6bps qoq to 2.01%, driven by effective loan pricing and funding cost management (compared to a NIM compression trend among peers); and ii) 11% yoy growth in non-interest income (realized trading and investment gains).
HLB’s gross impaired loan (GIL) ratio saw a 5bps uptick from 0.79% in 4QFY16 to 0.84% in 1QFY17, as gross impaired loans grew by 6% qoq due to a corporate account (under R&R, fully collateralized), personal loans and auto loans. In our view, there is no cause to be concerned.
We maintain our HOLD rating on HLB at our revised 12M PT of RM13.00 (equivalent to a 1.18x P/BV multiple, based on a FY17E’s ROE of 10.4%) from RM13.30 as we revise down FY17-19E earnings by 6.9-9.6%, driven by slower loan growth (4.3-4.6% yoy) and a potential contraction in NIM to around 1.92%. We remain neutral on the group’s outlook, as FY17 is expected to see a marginal EPS growth due to less upbeat domestic sentiment although supported by improving overseas contribution (11-12% of pre-tax profit). Downside risks: i) slowdown in economic growth; and ii) asset-quality issues. Upside risks: i) higher impaired loan recoveries; ii) increased revenue from reinvestments/redeployment of MSS cost-savings.
Source: Affin Hwang Research - 23 Nov 2016
Chart | Stock Name | Last | Change | Volume |
---|
2024-08-08
HLBANK2024-08-07
HLBANK2024-08-07
HLBANK2024-08-06
HLBANK2024-08-06
HLBANK2024-08-06
HLBANK2024-08-06
HLBANK2024-08-05
HLBANK2024-08-05
HLBANK2024-08-03
HLBANK2024-08-02
HLBANK2024-08-02
HLBANK2024-08-01
HLBANK2024-08-01
HLBANK2024-08-01
HLBANK2024-08-01
HLBANK2024-07-29
HLBANKCreated by kltrader | Jan 03, 2023
Created by kltrader | Sep 30, 2022